Skip to main content
. 2022 Nov 28;13:1061029. doi: 10.3389/fendo.2022.1061029

Table 2.

Presurgical medication and somatostatin receptor scintigraphy.

Overall Male Female p-value
Preoperative SSA 56/65 18/22 39/43 0.427
Short-term SSA 30 6 25 0.054
Long-term SSA 26 12 14
No use of SSA 9 5 4
Medication time
(short-term)/weeks (n = 29)
1.4 (1.0, 2.0) 1.35 (0.55, 2.23) 1.4 (1.0, 2.0) 0.854
Medication time
(long-term)/weeks (n = 26)
12.0 (8.0, 14.13) 12.0 (5.75, 13.13) 12.0 (11.0, 16.0) 0.462
Time for hormonal control
(short-term)/days (n = 22)
2.5 (2.0, 5.25) 2.0 (1.0, 4.0) 3.0 (2.0, 6.0) 0.249
Time for hormonal control
(long-term)/weeks (n = 16)
4.0 (1.0, 8.5) 4.0 (1.0, 10.0) 4.0 (1.0, 4.0) 0.536
Somatostatin receptor scintigraphy (+) 40/53 13/17 27/36 1.00